DDInter248 DDInter1224
Bumetanide is a sulfamyl diuretic.
Minocycline was first described in the literacture in 1966. It is a second generation tetracycline antibiotic that is active against gram-negative and gram-positive bacteria. Like other semisynthetic tetracyclines, minocycline has modifications to carbons 7-9 on the D ring to generate higher efficacy than previous tetracyclines. Minocycline was granted FDA approval on 30 June 1971.
Bumetanide {u} (Compound) binds {v} (Gene) SLC22A8
SLC22A8 {u} (Gene) is bound by {v} (Compound) Minocycline
Bumetanide {u} (Compound) resembles {v} (Compound) Indapamide
Indapamide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Minocycline
Bumetanide {u} (Compound) binds {v} (Gene) SLC22A8
SLC22A8 {u} (Gene) is bound by {v} (Compound) Doxycycline
Doxycycline {u} (Compound) resembles {v} (Compound) Minocycline
Bumetanide {u} (Compound) binds {v} (Gene) SLC22A7
SLC22A7 {u} (Gene) is bound by {v} (Compound) Oxytetracycline
Oxytetracycline {u} (Compound) resembles {v} (Compound) Minocycline
Bumetanide {u} (Compound) resembles {v} (Compound) Furosemide
Furosemide {u} (Compound) resembles {v} (Compound) Indapamide
Indapamide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Minocycline
Bumetanide {u} (Compound) resembles {v} (Compound) Indapamide
Indapamide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Doxycycline
Doxycycline {u} (Compound) resembles {v} (Compound) Minocycline
Bumetanide {u} (Compound) resembles {v} (Compound) Fenoprofen
Fenoprofen {u} (Compound) resembles {v} (Compound) Warfarin
Warfarin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Minocycline
Bumetanide {u} (Compound) resembles {v} (Compound) Furosemide
Furosemide {u} (Compound) binds {v} (Gene) SLC22A8
SLC22A8 {u} (Gene) is bound by {v} (Compound) Minocycline
Bumetanide {u} (Compound) resembles {v} (Compound) Indapamide
Indapamide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Oxytetracycline
Oxytetracycline {u} (Compound) resembles {v} (Compound) Minocycline
Bumetanide {u} (Compound) binds {v} (Gene) SLC22A7
SLC22A7 {u} (Gene) is bound by {v} (Compound) Methotrexate
Methotrexate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Minocycline
Bumetanide (Compound) binds SLC22A8 (Gene) and SLC22A8 (Gene) is bound by Minocycline (Compound)
Bumetanide (Compound) resembles Indapamide (Compound) and Indapamide may cause a minor interaction that can limit clinical effects when taken with Minocycline
Bumetanide (Compound) binds SLC22A8 (Gene) and SLC22A8 (Gene) is bound by Doxycycline (Compound) and Doxycycline (Compound) resembles Minocycline (Compound)
Bumetanide (Compound) binds SLC22A7 (Gene) and SLC22A7 (Gene) is bound by Oxytetracycline (Compound) and Oxytetracycline (Compound) resembles Minocycline (Compound)
Bumetanide (Compound) resembles Furosemide (Compound) and Furosemide (Compound) resembles Indapamide (Compound) and Indapamide may cause a minor interaction that can limit clinical effects when taken with Minocycline
Bumetanide (Compound) resembles Indapamide (Compound) and Indapamide may cause a minor interaction that can limit clinical effects when taken with Doxycycline and Doxycycline (Compound) resembles Minocycline (Compound)
Bumetanide (Compound) resembles Fenoprofen (Compound) and Fenoprofen (Compound) resembles Warfarin (Compound) and Warfarin may cause a moderate interaction that could exacerbate diseases when taken with Minocycline
Bumetanide (Compound) resembles Furosemide (Compound) and Furosemide (Compound) binds SLC22A8 (Gene) and SLC22A8 (Gene) is bound by Minocycline (Compound)
Bumetanide (Compound) resembles Indapamide (Compound) and Indapamide may cause a minor interaction that can limit clinical effects when taken with Oxytetracycline and Oxytetracycline (Compound) resembles Minocycline (Compound)
Bumetanide (Compound) binds SLC22A7 (Gene) and SLC22A7 (Gene) is bound by Methotrexate (Compound) and Methotrexate may cause a moderate interaction that could exacerbate diseases when taken with Minocycline